Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: other routes
Type of information:
experimental study
Adequacy of study:
other information
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Study meets basic scientific principles, sufficiently documented

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1980
Report date:
1980

Materials and methods

Test guideline
Qualifier:
no guideline followed
GLP compliance:
no
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Citronellal
EC Number:
203-376-6
EC Name:
Citronellal
Cas Number:
106-23-0
Molecular formula:
C10H18O
IUPAC Name:
3,7-dimethyloct-6-enal
Details on test material:
Name of test material (as cited in study report): Citronellal (78/742)

Test animals

Species:
mouse
Strain:
NMRI
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Wiga
- Weight at study initiation: 22-28 g (male); 22-24 g (female)
- Fasting period before study: 15 -20 hours prior to application

Administration / exposure

Route of administration:
intraperitoneal
Vehicle:
CMC (carboxymethyl cellulose)
Doses:
200, 700 mg/kg
No. of animals per sex per dose:
5
Details on study design:
- Duration of observation period following administration: 15 days
- Frequency of observations: 15 min, 30 min, 1 h, 2 h, 4 h, 5 h, d 1-9, d 12-15; weighing: before exposure, d 2-4, d 7, d 13
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight
Statistics:
Statistic test on significance performed (no further details given)

Results and discussion

Effect levels
Sex:
male/female
Dose descriptor:
LD50
Effect level:
> 200 - < 700 mg/kg bw
Mortality:
700 mg/kg: male: (5/5) day 1; female: (5/5) day 1;
200 mg/kg: male: (0/5) day 15; female: (0/5) day 15
Clinical signs:
see Table 1
Body weight:
see Table 2
Gross pathology:
no intra-abdominal precipitations or adhesions; no further findings were reported

Any other information on results incl. tables

Table 1: Clinical signs

Dose (mg/kg)

700

200

dyspnoea

***

***

apathy

***

***

abnormal position

***

tumbling

***

***

atony

***

twitches

***

spasmic movement

***

Saltation convulsions

***

clonic cramps

***

erythema

***

exsicosis

***

overbalance

***

disturbance of equilibrium

***

paresis

***

poor general condition

***

***

Table 2: Mortality and body weight gain

Dose (mg/kg)

700*

200*

sex

male

female

male

female

number of animals

5

5

5

5

dead animals after 1 hour

1

1

0

0

1 day 

5

5

0

0

2 days

5

5

0

0

7 days

5

5

0

0

15 days

5

5

0

0

mean body weight gain (g)

-

-

7.2

4.8

* used for LD50 calculation

LD50 > 200 mg/kg (statistical significance: 1%)

LD50 < 700 mg/kg (statistical significance: 1%)

observation period 15 days (male and female animals)

Applicant's summary and conclusion